Journal
IDCASES
Volume 24, Issue -, Pages -Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.idcr.2021.e01111
Keywords
COVID-19; Cytomegalovirus infections; Rectal diseases; Proctitis; Dexamethasone; Anakinra
Categories
Ask authors/readers for more resources
This case report describes a patient with reactivated cytomegalovirus proctitis complicating severe COVID-19 pneumonia treated with dexamethasone, anakinra, and lopinavir/ritonavir. The herpes virus proctitis was attributed to iatrogenic immunosuppression and immune dysregulation related to COVID-19, highlighting the immunosuppressive risks associated with using immunomodulators in the treatment of severe COVID-19 pneumonia.
We report a case of reactivated biopsy-proven cytomegalovirus proctitis complicating the course of severe COVID-19 pneumonia treated with dexamethasone, anakinra and lopinavir/ritonavir. No other contributing factor was found than iatrogenic immunosuppression and COVID-19 immune dysregulation. We draw attention to the immunosuppressive risk when treating severe COVID-19 pneumonia with immunomodulators. (C) 2021 The Authors. Published by Elsevier Ltd.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available